GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
BrainStorm Cell Therapeutics is a biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases.
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases.